Weight loss in HCV patients can be used as a surrogate marker for evaluation of interferon (IFN-alpha) treatment efficacy-A prospective pilot study

DSpace Repository

Weight loss in HCV patients can be used as a surrogate marker for evaluation of interferon (IFN-alpha) treatment efficacy-A prospective pilot study

Author: Alam, Ibrar; Alam, Iftikhar; Ali, Ijaz; Ali, Muhammad
Tübinger Autor(en):
Alam, Iftikhar
Published in: Pakistan Journal of Pharmaceutical Sciences (2014), Bd. 27, H. 3, S. 571-576
Verlagsangabe: Univ Karachi
Language: English
ISSN: 1011-601X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)